Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of ...

Nebius is a Strong Buy, reiterating 3.5GW contracted power, a 4GW target, and continued supply-constrained demand. Read more ...

In our monthly Rare Stock Picks series, we're highlighting June 2026 investment picks. Click here for the list of June 2026 ...

Crinetics adds potential best-in-class commercialized and Phase 3 endocrinology assets with ~$5 billion peak sales opportunity to Vertex's portfolio - PALSONIFY, Crinetics' recently launched, first ...

OmniESI：一个用于酶-底物相互作用预测的统一渐进式条件深度学习框架原文题名：OmniESI: A unified framework for enzyme-substrate interaction prediction with ...